Literature DB >> 21897487

The impact of adolescent pertussis immunization, 2004-2009: lessons from Australia.

Helen E Quinn1, Peter B McIntyre.   

Abstract

OBJECTIVE: To compare the impact of three strategies for delivering a booster dose of adult-formulated tetanus-diphtheria-pertussis (Tdap) vaccine to adolescents in Australia. These comprise: (i) administering Tdap to: a one-year age cohort; (ii) administering Tdap to the entire high school and to subsequent entrant cohorts; and (iii) administering Tdap to the entire high school but without continuing to immunize entrant cohorts.
METHODS: A series of ecologic analyses of pertussis notifications during epidemic periods in relevant age cohorts were conducted. The primary outcome measure was the incidence rate ratio (IRR), calculated by dividing pertussis incidence after the introduction of Tdap delivery programmes by pertussis incidence during the most recent pre-programme epidemic.
FINDINGS: During the epidemic period of 2008-2009, the national-level IRR among age cohorts targeted for Tdap was 0.6 (95% confidence interval, CI: 0.6-0.7), but among other age cohorts it was 1.1 (95% CI: 1.1-1.2). Only the jurisdiction that implemented strategy 2 (Western Australia) experienced sustained decreases in pertussis notifications in both adolescents and infants under 6 months of age (IRR: 0.4; 95% CI: 0.3-0.6) until 2009.
CONCLUSION: If confirmed by longer experience in Australia and elsewhere, a broad school-based catch-up programme followed by immunization of school entrants may be the optimum strategy for the implementation of adolescent Tdap programmes.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21897487      PMCID: PMC3165977          DOI: 10.2471/BLT.11.086538

Source DB:  PubMed          Journal:  Bull World Health Organ        ISSN: 0042-9686            Impact factor:   9.408


  22 in total

1.  A pertussis epidemic in NSW: how epidemiology reflects vaccination policy.

Authors:  Julia Brotherton; Jeremy McAnulty
Journal:  N S W Public Health Bull       Date:  2003 Apr-May

2.  Effect of the preschool pertussis booster on national notifications of disease in Australia.

Authors:  Siranda Torvaldsen; Peter B McIntyre
Journal:  Pediatr Infect Dis J       Date:  2003-11       Impact factor: 2.129

3.  Meeting of the Strategic Advisory Group of Experts on immunization, April 2010 - conclusions and recommendations.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2010-05-28

4.  Immunisation coverage annual report, 2008.

Authors:  Brynley P Hull; Deepika Mahajan; Aditi Dey; Rob I Menzies; Peter B McIntyre
Journal:  Commun Dis Intell Q Rep       Date:  2010-09

5.  School-based vaccination in NSW.

Authors:  Kirsten F Ward; Robert I Menzies; Helen E Quinn; Sue Campbell-Lloyd
Journal:  N S W Public Health Bull       Date:  2010 Sep-Oct

6.  Pertussis epidemiology in Australia over the decade 1995-2005--trends by region and age group.

Authors:  Helen E Quinn; Peter B McIntyre
Journal:  Commun Dis Intell Q Rep       Date:  2007-06

7.  Pertussis vaccine effectiveness after mass immunization of high school students in Australia.

Authors:  Claudia Rank; Helen E Quinn; Peter B McIntyre
Journal:  Pediatr Infect Dis J       Date:  2009-02       Impact factor: 2.129

8.  A boarding school outbreak of pertussis in adolescents: value of laboratory diagnostic methods.

Authors:  P Horby; C R Macintyre; P B McIntyre; G L Gilbert; M Staff; M Hanlon; L G Heron; M Cagney; C Bennett
Journal:  Epidemiol Infect       Date:  2005-04       Impact factor: 2.451

9.  Prevention of pertussis among adolescents: recommendations for use of tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis (Tdap) vaccine.

Authors: 
Journal:  Pediatrics       Date:  2005-12-28       Impact factor: 7.124

10.  Using computer simulations to compare pertussis vaccination strategies in Australia.

Authors:  Herbert W Hethcote; Peter Horby; Peter McIntyre
Journal:  Vaccine       Date:  2004-06-02       Impact factor: 3.641

View more
  17 in total

1.  Bordetella adenylate cyclase toxin interacts with filamentous haemagglutinin to inhibit biofilm formation in vitro.

Authors:  Casandra Hoffman; Joshua Eby; Mary Gray; F Heath Damron; Jeffrey Melvin; Peggy Cotter; Erik Hewlett
Journal:  Mol Microbiol       Date:  2016-11-03       Impact factor: 3.501

Review 2.  Pertussis re-emergence in the post-vaccination era.

Authors:  Elena Chiappini; Alessia Stival; Luisa Galli; Maurizio de Martino
Journal:  BMC Infect Dis       Date:  2013-03-26       Impact factor: 3.090

Review 3.  Pertussis: Microbiology, Disease, Treatment, and Prevention.

Authors:  Paul E Kilgore; Abdulbaset M Salim; Marcus J Zervos; Heinz-Josef Schmitt
Journal:  Clin Microbiol Rev       Date:  2016-07       Impact factor: 26.132

4.  Increased population prevalence of low pertussis toxin antibody levels in young children preceding a record pertussis epidemic in Australia.

Authors:  Patricia Campbell; Peter McIntyre; Helen Quinn; Linda Hueston; Gwendolyn L Gilbert; Jodie McVernon
Journal:  PLoS One       Date:  2012-04-27       Impact factor: 3.240

5.  Risk factors for pertussis in adults and teenagers in England.

Authors:  A Wensley; G J Hughes; H Campbell; G Amirthalingam; N Andrews; N Young; L Coole
Journal:  Epidemiol Infect       Date:  2017-01-09       Impact factor: 4.434

6.  Modelling pertussis transmission to evaluate the effectiveness of an adolescent booster in Argentina.

Authors:  G Fabricius; P E Bergero; M E Ormazabal; A L Maltz; D F Hozbor
Journal:  Epidemiol Infect       Date:  2012-07-06       Impact factor: 4.434

Review 7.  Perplexities of pertussis: recent global epidemiological trends and their potential causes.

Authors:  D W Jackson; Pejman Rohani
Journal:  Epidemiol Infect       Date:  2013-01-16       Impact factor: 4.434

8.  Evaluating the implementation of the 13-valent pneumococcal vaccine supplementary dose program in Australian primary health care settings.

Authors:  Kirsten F Ward; Marianne Trent; Brynley P Hull; Helen E Quinn; Aditi Dey; Robert I Menzies
Journal:  BMC Health Serv Res       Date:  2015-03-18       Impact factor: 2.655

9.  Infectious diseases and vaccination strategies: how to protect the "unprotectable"?

Authors:  Elena Bozzola; Mauro Bozzola; Valeria Calcaterra; Salvatore Barberi; Alberto Villani
Journal:  ISRN Prev Med       Date:  2013-04-03

10.  Report of a pertussis outbreak in a low coverage booster vaccination group of otherwise healthy children in Italy.

Authors:  Silvio Tafuri; Maria Serena Gallone; Domenico Martinelli; Rosa Prato; Maria Chironna; Cinzia Germinario
Journal:  BMC Infect Dis       Date:  2013-11-14       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.